企業プロフィール · Healthcare

Cardinal Health Inc

CAH · 米国株
取引所
米国株
国 / 地域
USA
上場日
1987年12月31日
従業員数
53,084
公式サイト
www.cardinalhealth.com
現在値
$221.77
リアルタイム · 2026年6月18日
ベイリー成長スコア
41/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $221.77 リアルタイム · 妥当レンジと楽観的レンジの間

総合バリュエーションレンジ · 保守的 $130–$160 / 妥当 $175–$215 / 楽観的 $240–$300。$221.77 時点で 妥当レンジと楽観的レンジの間。

レポート公開時 $200.68(2026年5月24日)

この銘柄のレポートはお使いの言語でまだありません。

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

時価総額$529.96億
売上高(TTM)$2507.35億
EBITDA$39.94億
純利益率0.62%
ROE0%
PER (TTM)34.6
予想PER19.05
PEG1.4
EPS$6.54
配当利回り0.9%
52週レンジ$136.63 – $233.04
アナリスト目標株価$245.27
アナリスト評価4.1 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。